Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
PLoS One ; 17(6): e0268587, 2022.
Article in English | MEDLINE | ID: covidwho-1875092

ABSTRACT

BACKGROUND: Vaccines are effective in preventing Coronavirus Disease 2019 (COVID-19). Vaccine hesitancy defined as delay of acceptance or refusal of the vaccine is a major barrier to effective implementation. METHODS: Participants were recruited statewide through an English and Spanish social media marketing campaign conducted by a local news station during a one-month period as vaccines were becoming available in Rhode Island (from December 21, 2020 to January 22, 2021). Participants completed an online survey about COVID-19 vaccines and vaccine hesitancy with constructs and items adopted from the Health Belief Model. RESULTS: A total of 2,007 individuals completed the survey. Eight percent (n = 161) reported vaccine hesitancy. The sample had a median age of 58 years (interquartile range [IQR]: 45, 67), were majority female (78%), White (96%), Non-Hispanic (94%), employed (58%), and reported an annual individual income of $50,000 (59%). COVID-19 vaccine hesitancy was associated with attitudes and behaviors related to COVID-19. A one unit increase in concern about COVID-19 was associated with a 69% (Adjusted Odds Ratio: 0.31, 95% CI: 0.26-0.37) decrease in vaccine hesitancy. A one-level increase in the likelihood of getting influenza vaccine was associated with a 55% (AOR: 0.45 95% CI: 0.41-0.50) decrease in vaccine hesitancy. CONCLUSIONS: COVID-19 vaccine hesitancy was relatively low in a state-wide survey in Rhode Island. Future research is needed to better understand and tailor messaging related to vaccine hesitancy.


Subject(s)
COVID-19 , Influenza Vaccines , Urogenital Abnormalities , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Vaccines , Female , Humans , Middle Aged , Patient Acceptance of Health Care , Rhode Island/epidemiology , Vaccination Hesitancy
2.
Arch Sex Behav ; 50(5): 2007-2016, 2021 07.
Article in English | MEDLINE | ID: covidwho-1147601

ABSTRACT

COVID-19 has disproportionately affected vulnerable populations across the U.S. Street-based sex workers are one vulnerable population whose health and impact of COVID-19 have been understudied to date. The goal of this study was to evaluate findings from a community needs assessment with street-based sex workers on impact of COVID-19 on health behaviors and social circumstances. A brief survey was developed at a community-based harm reduction and recovery services organization. Surveys were administered by peer specialists to street-based sex workers during street outreach in April and May 2020. A total of 46 surveys were analyzed. Many individuals reported continuing to do sex work and use substances during the COVID pandemic. Slightly more than a quarter of individuals (n = 13; 28.3%) indicated using personal protective equipment while doing sex work and described challenges to using precautions when working with clients. Individuals had used marijuana (n = 32, 71.1%), cocaine (n = 17, 39.5%), prescription stimulants (n = 9, 21.4%), methamphetamines (n = 5, 11.9%), prescription opioids (n = 12, 27.3%), street opioids (n = 12, 27.3%), sedatives (n = 11, 25.0%), hallucinogens (n = 3, 6.8%), inhalants (n = 3, 7.0%), or some other substance (n = 4, 8.7%) in the past 30 days. About half (48.8%) reported that COVID-19 had a major impact on their lives. This study is among the first to characterize the impact of COVID-19 on street-based sex workers. From a public health standpoint, this group also represents a high-priority population given their vulnerability and close contact with others, which increases the potential for community spread.


Subject(s)
COVID-19/epidemiology , HIV Infections/epidemiology , Sex Workers/statistics & numerical data , Vulnerable Populations , Adolescent , Adult , Female , Gender Identity , Humans , Male , Middle Aged , SARS-CoV-2 , Syndemic , Young Adult
3.
Am J Public Health ; 111(4): 700-703, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1088805

ABSTRACT

Objectives. To characterize statewide seroprevalence and point prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Rhode Island.Methods. We conducted a cross-sectional survey of randomly selected households across Rhode Island in May 2020. Antibody-based and polymerase chain reaction (PCR)-based tests for SARS-CoV-2 were offered. Hispanics/Latinos and African Americans/Blacks were oversampled to ensure adequate representation. Seroprevalence estimations accounted for test sensitivity and specificity and were compared according to age, race/ethnicity, gender, housing environment, and transportation mode.Results. Overall, 1043 individuals from 554 households were tested (1032 antibody tests, 988 PCR tests). The estimated seroprevalence of SARS-CoV-2 antibodies was 2.1% (95% credible interval [CI] = 0.6, 4.1). Seroprevalence was 7.5% (95% CI = 1.3, 17.5) among Hispanics/Latinos, 3.8% (95% CI = 0.0, 15.0) among African Americans/Blacks, and 0.8% (95% CI = 0.0, 2.4) among non-Hispanic Whites. Overall PCR-based prevalence was 1.5% (95% CI = 0.5, 3.1).Conclusions. Rhode Island had low seroprevalence relative to other settings, but seroprevalence was substantially higher among African Americans/Blacks and Hispanics/Latinos. Rhode Island sits along the highly populated northeast corridor, making our findings broadly relevant to this region of the country. Continued monitoring via population-based sampling is needed to quantify these impacts going forward.


Subject(s)
COVID-19 Serological Testing , COVID-19 , Seroepidemiologic Studies , Adolescent , Adult , Aged , COVID-19/epidemiology , COVID-19/ethnology , Child , Child, Preschool , Cross-Sectional Studies , Ethnicity/statistics & numerical data , Family Characteristics , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Rhode Island/epidemiology , Young Adult
4.
Sex Transm Dis ; 48(1): e5-e7, 2021 01.
Article in English | MEDLINE | ID: covidwho-977420

ABSTRACT

Coronavirus disease 2019 is responsible for a global pandemic and has impacted health care accessibility and delivery. Clinic data were reviewed for an STI clinic from September 2019 to May 2020. A significant decrease in rates of STI visits and treatments during the coronavirus disease 2019 pandemic was observed.


Subject(s)
Ambulatory Care Facilities/statistics & numerical data , Ambulatory Care/statistics & numerical data , COVID-19/epidemiology , Health Services Accessibility/statistics & numerical data , Sexually Transmitted Diseases/epidemiology , Humans , Pandemics , Rhode Island , Sexually Transmitted Diseases/prevention & control
6.
Sex Transm Dis ; 47(7): 431-433, 2020 07.
Article in English | MEDLINE | ID: covidwho-599017

ABSTRACT

Coronavirus disease (COVID-19) is responsible for a global pandemic. It is important to balance the need for access to healthcare services, including testing and treatment for sexually transmitted infections. Sexually transmitted infection programs must consider how to use limited resources and implement novel approaches to provide continued access to care.


Subject(s)
Ambulatory Care Facilities/supply & distribution , Coronavirus Infections/epidemiology , Health Services Accessibility/organization & administration , Pneumonia, Viral/epidemiology , Reproductive Health Services/supply & distribution , Sexually Transmitted Diseases , Betacoronavirus , COVID-19 , Coronavirus Infections/complications , Coronavirus Infections/virology , Humans , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/virology , SARS-CoV-2 , Sexually Transmitted Diseases/virology
SELECTION OF CITATIONS
SEARCH DETAIL